Table 1.
Histotypes | WHO Grade | Frequent Age at Diagnosis | Mitotic Count (mitosis/10HPF) |
Ki67/Mib1 LI (%) |
Most Frequent Molecular Alterations |
---|---|---|---|---|---|
PC | 1 | adult | <0–1 | 1–2 | n.s. |
PPTID | 2 | adult | <5 | 6–10 | KBTBD4 (insertion); ATRX loss of function |
3 | 5 | 10–20 | |||
PB (subtypes) | |||||
PB-miRNA1 | 4 | older children or young adult | High mitotic count | 20–25% and up to 50 or more | DICER1, DROSHA, DGCR8 (loss of function) |
PB-miRNA2 | DICER1, DROSHA (loss of function) |
||||
PB-MYC/FOXR2 | Infant or young children | FOXR2 overexpression; MYC activation | |||
PB-RB1 | RB1 loss of function | ||||
DMT-SMARCB1-mut | TBD | young adult | <0–1 | 3 | SMARCB1 loss of function |
PTPR | 2 | young adult | <2–3 | 2–3 | PTEN mutation; PI3K alteration |
3 | ≥3 | ≥10 |